Shields Health Solutions and Sutter Health Expand Collaboration to Enhance Patient Access to Specialty Pharmacy Serviceshttps://shieldshealthsolutions.com/content/uploads/2021/06/shields-blog-icon-pr-1.svg204115Shields Health SolutionsShields Health Solutions//shieldshealthsolutions.com/content/uploads/2021/05/shields-logo-white.svg
STOUGHTON, Mass. & SACRAMENTO, Calif.—(BUSINESS WIRE)—Shields Health Solutions (Shields), the premier specialty pharmacy accelerator in the United States and a Walgreens-owned company, has expanded its work with Sutter Health, one…
Exploring AI’s Potential to Transform Specialty Pharmacyhttps://shieldshealthsolutions.com/content/uploads/2021/06/shields-blog-icon-case-whitepaper.svg204115Shields Health SolutionsShields Health Solutions//shieldshealthsolutions.com/content/uploads/2021/05/shields-logo-white.svg
This white paper explores the opportunities and unknowns that health organizations must consider when weighing the implementation of AI.
Shields Health Solutions and UnityPoint at Home Extend Collaboration, Providing Patients and Families Enhanced Specialty Pharmacy Serviceshttps://shieldshealthsolutions.com/content/uploads/2021/06/shields-blog-icon-pr-1.svg204115Shields Health SolutionsShields Health Solutions//shieldshealthsolutions.com/content/uploads/2021/05/shields-logo-white.svg
Shields and UnityPoint at Home have expanded their partnership providing patients with complex, chronic conditions access to specialized pharmacy services designed to lower costs, broaden treatment options, enhance medication management, and improve overall health.
Hep-C Outcomes 2023https://shieldshealthsolutions.com/content/uploads/2023/10/web-resources-icon-HepC.png216115Shields Health SolutionsShields Health Solutions//shieldshealthsolutions.com/content/uploads/2021/05/shields-logo-white.svg
Hepatitis C is a liver infection caused by the hepatitis C virus (HCV) and is spread through contact with the blood of an infected person.
RA Outcomes 2023https://shieldshealthsolutions.com/content/uploads/2023/10/web-resources-icon-RA.png216115Shields Health SolutionsShields Health Solutions//shieldshealthsolutions.com/content/uploads/2021/05/shields-logo-white.svg
RA is an autoimmune and inflammatory disease where the immune system attacks healthy cells, causing inflammation and painful swelling in the affected parts of the body.
MS Outcomes 2023https://shieldshealthsolutions.com/content/uploads/2023/10/web-resources-icon-MS-Outcomes.png216115Shields Health SolutionsShields Health Solutions//shieldshealthsolutions.com/content/uploads/2021/05/shields-logo-white.svg
MS is a chronic, autoimmune disease of the central nervous system, affecting the communication between the brain and other parts of the body
Oncology Outcomes 2023https://shieldshealthsolutions.com/content/uploads/2024/04/Outcomes_06-1-1024x1024.png10241024Shields Health SolutionsShields Health Solutions//shieldshealthsolutions.com/content/uploads/2021/05/shields-logo-white.svg
Cancer, a genetic disease in which some of the body’s cells grow uncontrollably and spread to other parts of the body, is caused by changes to genes that control the…
Evaluation of a Social Determinants of Health Screening and Intervention Framework within an Integrated Health System Specialty Pharmacy Care Model Using a Closed-Loop Referral Processhttps://shieldshealthsolutions.com/content/uploads/2023/05/web-resources-icon-posters.png216115Shields Health SolutionsShields Health Solutions//shieldshealthsolutions.com/content/uploads/2021/05/shields-logo-white.svg
This poster presents an evaluation of a social determinants of health screening and intervention framework within an integrated health system specialty pharmacy care model using a closed-loop referral process.
Clinical Outcomes in Cystic Fibrosis Patients Enrolled in an Integrated Health System Specialty Pharmacy Care Modelhttps://shieldshealthsolutions.com/content/uploads/2023/05/web-resources-icon-posters.png216115Shields Health SolutionsShields Health Solutions//shieldshealthsolutions.com/content/uploads/2021/05/shields-logo-white.svg
This poster presents an evaluation of outcomes in cystic fibrosis (CF) patients within a health system specialty pharmacy care model by comparing them to established benchmarks.
Clinical Outcomes of Migraine Patients Receiving Calcitonin Gene-Related Peptide Antagonists from an Integrated Health System Specialty Pharmacyhttps://shieldshealthsolutions.com/content/uploads/2023/05/web-resources-icon-posters.png216115Shields Health SolutionsShields Health Solutions//shieldshealthsolutions.com/content/uploads/2021/05/shields-logo-white.svg
This poster evaluates the percent reduction in patient-reported monthly migraine days of patients receiving CGRPs from an integrated health system specialty pharmacy (HSSP).